Abstracts Archive - Page 1236 of 2607 - ACR Meeting Abstracts

Abstract Number: 745 • 2018 ACR/ARHP Annual Meeting
Prolonged Remission and Influence on Damage Accrual and Infection for Patients with Systemic Lupus Erythematosus: A Multi-Center Cohort Study from China
Ziqian Wang¹, Jiuliang ZHAO², Yanhong Wang³, Mengtao Li⁴ and Xiaofeng Zeng⁵, ¹Peking Union Medical College Hospital, China, Beijing, China, ²Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, China, ³Department of Epidemiology and Bio-statistics (YW), Academy of Medical Sciences & Peking Union Medical College, Beijing, China, ⁴Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China, ⁵Rheumatology, Peking Union Medical College and Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China
Prolonged Remission and Influence on Damage Accrual and Infection for Patients with Systemic Lupus Erythematosus: a Multi-center Cohort Study from ChinaZiqian Wang1, Jiuliang Zhao1, Yanhong…
Abstract Number: 746 • 2018 ACR/ARHP Annual Meeting
Impact of Nephritis on the Outcomes of SLE Patients Hospitalized with Acute Myocardial Infarction; Insights from the National Inpatient Sample Database
Atefeh Vafa¹, Setri Fugar², Chimezie Mbachi¹ and John P. Case^3,4, ¹Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, ²Cardiology, Rush University Medical Center, Chicago, IL, ³Internal Medicine/Rheumatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, ⁴Internal Medicine, Chicago Medical School, North Chicago, IL
Background/Purpose: Early cardiovascular disease is an important cause of mortality in SLE. Previous studies have shown that lupus nephritis (LN) was associated with an increased…
Abstract Number: 747 • 2018 ACR/ARHP Annual Meeting
The Influence of Depression on Clinical Features of Systemic Lupus Erythematosus
Amanda M. Eudy¹, Jennifer Rogers², Lisa Criscione-Schreiber¹, David Pisetsky³, Kai Sun⁴, Jay Doss⁴ and Megan E. B. Clowse¹, ¹Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC, ²Medicine, Divison of Rheumatology, Duke University, Durham, NC, ³Department of Medicine, Duke University, Durham, NC, ⁴Division of Rheumatology & Immunology, Duke University, Durham, NC
Background/Purpose: Depression occurs commonly among patients with SLE. In this study, we used two separate scales to assess depression and determined differences in clinical characteristics…
Abstract Number: 748 • 2018 ACR/ARHP Annual Meeting
Long-Term Survival of Renal Transplantation Due to Lupus Nephritis. Comparative Study with Non-Autoimmune Transplantation. Study from a Single Center
Lara Sánchez-Bilbao¹, Belén Atienza-Mateo¹, José Luis Martín-Varillas¹, Marina de Cos-Gómez², Íñigo González-Mazón¹, Diana Prieto Peña³, Monica Calderón Goercke³, Juan Carlos Ruiz San Millán², Emilio Rodrigo Calabia², Miguel Angel González-Gay¹ and Ricardo Blanco¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Nephrology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain
Background/Purpose: Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus, affecting up to 40% of patients. Unfortunately, about 20% of LN develop end…
Abstract Number: 749 • 2018 ACR/ARHP Annual Meeting
Is Lupus Nephritis Onset Delayed in Older Caucasian Females with Less Aggressive Pathology?
Cristina Arriens¹, Sixia Chen², David Karp³, Ramesh Saxena⁴, Joan T. Merrill¹ and Judith A. James⁵, ¹Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ³Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX, ⁴Nephrology Division, UT Southwestern Medical Center, Dallas, TX, ⁵Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK
Background/Purpose: Lupus Nephritis (LN) usually presents within 5 years of SLE diagnosis, however the minority of patients with late-occurring nephritis are poorly characterized. Factors associated…
Abstract Number: 750 • 2018 ACR/ARHP Annual Meeting
Positive Remodeling Index and Low Attenuation Non-Calcified Coronary Plaques: Markers of Vulnerable Coronary Plaques in Systemic Lupus?
George Stojan¹, Laurence Magder² and Michelle Petri³, ¹Division of Rheumatology, Johns Hopkins University, Baltimore, MD, ²Department of Epidemiology, University of Maryland, Baltimore, MD, ³Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Accelerated atherosclerosis leading to premature coronary artery disease remains the major cause of late death in SLE. Positive remodeling index and presence of low…
Abstract Number: 751 • 2018 ACR/ARHP Annual Meeting
Coronary Plaque Burden in Patients with Lupus Compared to Healthy Volunteers
George Stojan¹, Matthew Budoff², Laurence Magder³, Jessica Li⁴, Armin Zadeh⁵, Erik Barr⁶ and Michelle Petri⁵, ¹Division of Rheumatology, Johns Hopkins University, Baltimore, MD, ²Cardiology, Harbor-UCLA Medical Center, Torrance, CA, ³Department of Epidemiology, University of Maryland, Baltimore, MD, ⁴Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Johns Hopkins University School of Medicine, Baltimore, MD, ⁶Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD
Background/Purpose: Accelerated atherosclerosis leading to premature coronary artery disease remains the major cause of late death in SLE. We sought to characterize noncalcified and calcified…
Abstract Number: 752 • 2018 ACR/ARHP Annual Meeting
Prevalence and Predictors of Peripheral Vascular Disease in a Cohort of Systemic Lupus Erythematosus (SLE) Patients
Ida Dzifa Dey¹, Kelvin Acquaye², Alfred Yawson³, Kofi Agyabeng⁴, Ernest Yorke⁵, Vincent Boima⁶ and Charles Mate-Kole⁷, ¹Department of Medicine, Rheumatology Unit, School of Medicine and Dentistry,University of Ghana, Accra, Ghana, ²Department of Psychology, School of Medicine and Dentistry, Accra, Ghana, ³Department of Community Health, School of Medicine and Dentistry, Accra, Ghana, ⁴Department of Community Health, School of Medicine and Dentistry,University of Ghana, Accra, Ghana, ⁵Medicine, School of Medicine and Dentistry,University of Ghana, Accra, Ghana, ⁶School of Medicine and Dentistry,University of Ghana, Accra, Ghana, ⁷Department of Psychology, School of Medicine and Dentistry, University of Ghana, Accra, Ghana
Background/Purpose: Low Ankle-brachial index (ABPI) < 0.9 demonstrating peripheral vascular disease (PVD), is a marker of subclinical cardiovascular disease and it is an inexpensive and…
Abstract Number: 753 • 2018 ACR/ARHP Annual Meeting
Young SLE Patients Have Higher Coronary Artery Calcium Scores Compared with Population Controls
Yevgeniya Gartshteyn¹, Genna Braverman², Sharan Mahtani³, Kayla Neville⁴, George Danias⁴, Laura Geraldino-Pardilla⁵, Sabahat Bokhari⁶ and Anca Askanase⁷, ¹Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, ²Internal Medicine, Columbia University Medical Center, New York, NY, ³College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom, ⁴Rheumatology, Columbia University Medical Center, New York, NY, ⁵Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, ⁶Cardiology, Columbia University, NY, NY, ⁷Columbia University, College of Physicians & Surgeons, New York, NY
Background/Purpose: Cardiovascular disease (CVD) is a leading cause of death in systemic lupus erythematosus (SLE). The coronary artery calcium (CAC) score is a surrogate for…
Abstract Number: 754 • 2018 ACR/ARHP Annual Meeting
Determinants of Major Neurocognitive Disorder (Vascular Dementia) in SLE: The Importance of Treatment Adherence of SLE Disease Activity and Cardiovascular Risk Factors
Jamal A. Mikdashi, Div of Rheumatology, Univ of Maryland Schl of Med, Baltimore, MD; Medicine/Rheum & Clinc Immun, University of Maryland School of Medicine, Baltimore, MD
Background/Purpose: Factors associated with neuropsychiatric damage in SLE has been described. Yet, determinants of progression of small vessel related brain injury, and major neurocognitive disorder-vascular…
Abstract Number: 755 • 2018 ACR/ARHP Annual Meeting
Elevated Serum Procalcitonin at Baseline Correlates with Reduced Survival in Patients with Lupus Myocarditis
Aadhaar Dhooria¹, Atit Gawalkar², Krishna Santosh², Adarsh MB¹, Aman Sharma³, Shefali Sharma², Sanjay Jain⁴ and Varun Dhir⁵, ¹Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, ²Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, ³Clinical Immunology and Rheumatology Services, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, ⁴Postgraduate Institute of Medical Education and Research, Chandigarh, India, CHANDIGARH, India, ⁵Internal Medicine (Rheumatology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India
Background/Purpose: Myocarditis is a severe manifestation of systemic lupus erythematosus (SLE). Ethnicity is believed to play an important role in influencing the outcome.We aimed to…
Abstract Number: 756 • 2018 ACR/ARHP Annual Meeting
Peripheral Neutrophil CD64 Index Combined with Biomarkers Improves the Ability of Diagnosing Bacterial Infection in Patients with SLE
Min Feng¹, Zhaojun Liang², Xiangcong Zhao¹, Chong Gao³ and Jing Luo⁴, ¹The Second Hospital of Shanxi Medical University, Taiyuan, China, ²Division of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China, Taiyuan, China, ³Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Cambridge, MA, ⁴the Second Hospital of Shanxi Medical University, Taiyuan, China
Background/Purpose: Patients with Systemic lupus erythematosus (SLE) are prone to bacterial infection owing to disease activity, abnormal immune function and long-term immunosuppressive therapy. Differentiating bacterial infection from…
Abstract Number: 757 • 2018 ACR/ARHP Annual Meeting
Urinary Galectin-3 Binding Protein As a Novel Biomarker of Renal Disease Activity in Lupus Nephritis
Huihua Ding¹, Cheng Ling², Roberto Bassi³, Shinji L Okitsu⁴, Julie A. DeMartino⁴ and Nan Shen¹, ¹Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, ²Department of Rheumatology, Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China, ³EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, ⁴TIP Immunology, EMD Serono Research and Development Institute, Inc., Billerica, MA
Background/Purpose: Lupus nephritis (LN) is one of the most common and severe manifestations of systemic lupus erythematosus (SLE). This study investigates urinary galecting-3 binding protein…
Abstract Number: 758 • 2018 ACR/ARHP Annual Meeting
Cutaneous Lupus Erythematosus Patients with a Negative ANA Meeting Acr and/or SLICC Criteria for Systemic Lupus Erythematosus
Meera Tarazi¹, Carolyn Kushner², Rebecca Gaffney² and Victoria P. Werth³, ¹Department of Dermatology, University of Pennsylvania, Philadelphia, PA, ²Dermatology, University of Pennsylvania, Philadelphia, PA, ³Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
Background/Purpose: Systemic lupus erythematosus (SLE) is a disorder that is heterogeneous and can be difficult to diagnose. One hallmark of the disease is the presence…
Abstract Number: 759 • 2018 ACR/ARHP Annual Meeting
Comparison of Length of Stay and Total Hospital Charges for Hospitalizations for Sepsis in Patients with Systemic Lupus Erythematosus: A Study of National Inpatient Sample Database 2010 to 2014
Karan Chugh¹, Shraddha Jatwani², Karan Jatwani³ and Jasleen Kaur⁴, ¹Division of Pulmonary, Critical Care & Sleep, Wayne State University/Detroit Medical Center, Detroit, MI, ²Department of Internal Medicine, Division of Rheumatology, Henry Ford Allegiance Health, Jackson, MI, ³Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital, New York, NY, ⁴Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI
Background/Purpose: Sepsis is a systemic inflammatory response syndrome caused by an infection with at least one acute organ failure and is major public health concern.1…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].